ALK-B.CO
Price:
$226.8
Market Cap:
$50.19B
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. It product portfolio include GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDACURE, and ITULAZAX for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food. It also provides consumer healthcare solution, which include Digital eco-system, a platform which connect and engages with allergy sufferers much earlier in the disease journey through tools and e-commerc...[Read more]
Industry
Biotechnology
IPO Date
2000-03-10
Stock Exchange
CPH
Ticker
ALK-B.CO
According to ALK-Abelló A/S’s latest financial reports and current stock price. The company's current Enterprise Value is 49.99B. This represents a change of 29.51% compared to the average of 38.60B of the last 4 quarters.
The mean historical Enterprise Value of ALK-Abelló A/S over the last ten years is 20.26B. The current 49.99B Enterprise Value has changed 24.58% with respect to the historical average. Over the past ten years (40 quarters), ALK-B.CO's Enterprise Value was at its highest in in the September 2025 quarter at 46.54B. The Enterprise Value was at its lowest in in the December 2017 quarter at 7.95B.
Average
20.26B
Median
20.08B
Minimum
8.01B
Maximum
38.14B
Discovering the peaks and valleys of ALK-Abelló A/S Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 62.26%
Maximum Annual Enterprise Value = 38.14B
Minimum Annual Increase = -43.23%
Minimum Annual Enterprise Value = 8.01B
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 35.81B | 57.95% |
| 2023 | 22.67B | 4.69% |
| 2022 | 21.65B | -43.23% |
| 2021 | 38.14B | 36.54% |
| 2020 | 27.94B | 51.03% |
| 2019 | 18.50B | 62.26% |
| 2018 | 11.40B | 42.37% |
| 2017 | 8.01B | -15.84% |
| 2016 | 9.51B | 6.06% |
| 2015 | 8.97B | 41.85% |
The current Enterprise Value of ALK-Abelló A/S (ALK-B.CO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
26.71B
5-year avg
29.24B
10-year avg
20.26B
ALK-Abelló A/S’s Enterprise Value is less than Demant A/S (59.72B), greater than Zealand Pharma A/S (27.99B), greater than H. Lundbeck A/S (43.16B), greater than Bavarian Nordic A/S (12.85B), greater than Ambu A/S (23.17B), greater than Gubra A/S (7.48B), greater than Pharma Equity Group A/S (137.07M), greater than GN Store Nord A/S (25.62B), greater than ChemoMetec A/S (11.53B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 59.72B | $44.68B | |
| 27.99B | $33.55B | |
| 43.16B | $34.23B | |
| 12.85B | $14.81B | |
| 23.17B | $23.39B | |
| 7.48B | $8.46B | |
| 137.07M | $119.32M | |
| 25.62B | $14.97B | |
| 11.53B | $11.87B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ALK-Abelló A/S using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ALK-Abelló A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is ALK-Abelló A/S's Enterprise Value?
What is the highest Enterprise Value for ALK-Abelló A/S (ALK-B.CO)?
What is the 3-year average Enterprise Value for ALK-Abelló A/S (ALK-B.CO)?
What is the 5-year average Enterprise Value for ALK-Abelló A/S (ALK-B.CO)?
How does the current Enterprise Value for ALK-Abelló A/S (ALK-B.CO) compare to its historical average?